» Articles » PMID: 36131001

Tracking SARS-COV-2 Variants Using Nanopore Sequencing in Ukraine in 2021

Overview
Journal Sci Rep
Specialty Science
Date 2022 Sep 21
PMID 36131001
Authors
Affiliations
Soon will be listed here.
Abstract

The use of real-time genomic epidemiology has enabled the tracking of the global spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), informing evidence-based public health decision making. Ukraine has experienced four waves of the Coronavirus Disease 2019 (COVID-19) between spring 2020 and spring 2022. However, insufficient capacity for local genetic sequencing limited the potential application of SARS-CoV-2 genomic surveillance for public health response in the country. Herein, we report local sequencing of 103 SARS-CoV-2 genomes from patient samples collected in Kyiv in July-December 2021 using Oxford Nanopore technology. Together with other published Ukrainian SARS-CoV-2 genomes, our data suggest that the third wave of the epidemic in Ukraine (June-December 2021) was dominated by the Delta Variant of Concern (VOC). Our phylogeographic analysis revealed that in summer 2021 Delta VOC was introduced into Ukraine from multiple locations worldwide, with most introductions coming from Central and Eastern European countries. The wide geographic range of Delta introductions coincides with increased volume of travel to Ukraine particularly from locations outside of Europe in summer 2021. This study highlights the need to urgently integrate affordable and easily scaled pathogen sequencing technologies in locations with less developed genomic infrastructure, in order to support local public health decision making.

Citing Articles

From Omics to Multi-Omics: A Review of Advantages and Tradeoffs.

Hayes C, Nakahara H, Ono A, Tsuge M, Oka S Genes (Basel). 2025; 15(12.

PMID: 39766818 PMC: 11675490. DOI: 10.3390/genes15121551.


GCRTcall: a transformer based basecaller for nanopore RNA sequencing enhanced by gated convolution and relative position embedding via joint loss training.

Li Q, Sun C, Wang D, Lou J Front Genet. 2024; 15:1443532.

PMID: 39649096 PMC: 11621211. DOI: 10.3389/fgene.2024.1443532.


BaseNet: A transformer-based toolkit for nanopore sequencing signal decoding.

Li Q, Sun C, Wang D, Lou J Comput Struct Biotechnol J. 2024; 23:3430-3444.

PMID: 39391372 PMC: 11465205. DOI: 10.1016/j.csbj.2024.09.016.


The mortality burden related to COVID-19 in 2020 and 2021 - years of life lost and excess mortality in 13 countries and sub-national regions in Southern and Eastern Europe, and Central Asia.

Cawley C, Cakmak Barsbay M, Djamangulova T, Erdenebat B, Cilovic-Lagarija S, Fedorchenko V Front Public Health. 2024; 12:1378229.

PMID: 38903591 PMC: 11187286. DOI: 10.3389/fpubh.2024.1378229.


Genetic characteristics of SARS-CoV-2 virus variants observed upon three waves of the COVID-19 pandemic in Ukraine between February 2021-January 2022.

Gerashchenko G, Hryshchenko N, Melnichuk N, Marchyshak T, Chernushyn S, Demchyshina I Heliyon. 2024; 10(4):e25618.

PMID: 38380034 PMC: 10877268. DOI: 10.1016/j.heliyon.2024.e25618.


References
1.
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J . A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020; 382(8):727-733. PMC: 7092803. DOI: 10.1056/NEJMoa2001017. View

2.
Wu F, Zhao S, Yu B, Chen Y, Wang W, Song Z . A new coronavirus associated with human respiratory disease in China. Nature. 2020; 579(7798):265-269. PMC: 7094943. DOI: 10.1038/s41586-020-2008-3. View

3.
Tregoning J, Flight K, Higham S, Wang Z, Pierce B . Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape. Nat Rev Immunol. 2021; 21(10):626-636. PMC: 8351583. DOI: 10.1038/s41577-021-00592-1. View

4.
Worobey M, Pekar J, Larsen B, Nelson M, Hill V, Joy J . The emergence of SARS-CoV-2 in Europe and North America. Science. 2020; 370(6516):564-570. PMC: 7810038. DOI: 10.1126/science.abc8169. View

5.
du Plessis L, McCrone J, Zarebski A, Hill V, Ruis C, Gutierrez B . Establishment and lineage dynamics of the SARS-CoV-2 epidemic in the UK. Science. 2021; 371(6530):708-712. PMC: 7877493. DOI: 10.1126/science.abf2946. View